why choose us

First received: August 19, 2024

Clinical Trial: First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Duchenne Muscular Dystrophy

Study Type: INTERVENTIONAL


Official Title: Phase 1, Randomized, Double-blind, Placebo-controlled, Staggered, Parallel, Single and Multiple Ascending Dose and Food Effect Study to Evaluate the Safety and PK of Oral SAT-3247 in Healthy Volunteer

Brief Summary: This is a first-in-human (FIH), Phase 1 study of orally administered SAT-3247 in healthy adult volunteers (HVs) and adult participants with DMD to determine safety, tolerability, pharmacokinetics and pharmacodynamics.

Read more